139 related articles for article (PubMed ID: 10508282)
1. Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging.
Port RE; Knopp MV; Hoffmann U; Milker-Zabel S; Brix G
J Magn Reson Imaging; 1999 Sep; 10(3):233-41. PubMed ID: 10508282
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors.
Port RE; Knopp MV; Brix G
Magn Reson Med; 2001 Jun; 45(6):1030-8. PubMed ID: 11378881
[TBL] [Abstract][Full Text] [Related]
3. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours.
Mussurakis S; Buckley DL; Drew PJ; Fox JN; Carleton PJ; Turnbull LW; Horsman A
Clin Radiol; 1997 Jul; 52(7):516-26. PubMed ID: 9240704
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
[TBL] [Abstract][Full Text] [Related]
5. MR imaging of the breast with Gd-DTPA enhancement: comparison with mammography and ultrasonography.
Hachiya J; Seki T; Okada M; Nitatori T; Korenaga T; Furuya Y
Radiat Med; 1991; 9(6):232-40. PubMed ID: 1668410
[TBL] [Abstract][Full Text] [Related]
6. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging.
Daldrup-Link HE; Shames DM; Wendland M; Mühler A; Gossmann A; Rosenau W; Brasch RC
Acad Radiol; 2000 Nov; 7(11):934-44. PubMed ID: 11089696
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical studies on expression of human vascular smooth muscle myosin heavy chain isoforms in normal mammary glands, benign mammary disorders and mammary carcinomas.
Ohyabu I; Takasaki T; Akiba S; Nomura S; Enokizono N; Sagara Y; Hiroi J; Nagai R; Yoshida H
Pathol Int; 1998 Jun; 48(6):433-9. PubMed ID: 9702855
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of spontaneous canine breast tumors using dynamic magnetic resonance imaging with 24-Gadolinium-DTPA-cascade-polymer, a new blood-pool agent. Preliminary experience.
Adam G; Mühler A; Spüntrup E; Neuerburg JM; Kilbinger M; Bauer H; Fücezi L; Küpper W; Günther RW
Invest Radiol; 1996 May; 31(5):267-74. PubMed ID: 8724124
[TBL] [Abstract][Full Text] [Related]
11. A modified logistic model to describe gadolinium kinetics in breast tumors.
Moate PJ; Dougherty L; Schnall MD; Landis RJ; Boston RC
Magn Reson Imaging; 2004 May; 22(4):467-73. PubMed ID: 15120165
[TBL] [Abstract][Full Text] [Related]
12. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography.
Gribbestad IS; Nilsen G; Fjøsne HE; Kvinnsland S; Haugen OA; Rinck PA
J Magn Reson Imaging; 1994; 4(3):477-80. PubMed ID: 8061451
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiologic basis of contrast enhancement in breast tumors.
Knopp MV; Weiss E; Sinn HP; Mattern J; Junkermann H; Radeleff J; Magener A; Brix G; Delorme S; Zuna I; van Kaick G
J Magn Reson Imaging; 1999 Sep; 10(3):260-6. PubMed ID: 10508285
[TBL] [Abstract][Full Text] [Related]
14. PLASMINOGEN AND ANGIOSTATIN LEVELS IN FEMALE BENIGN BREAST LESIONS.
Tykhomyrov AA; Vovchuk IL; Grinenko TV
Ukr Biochem J; 2015; 87(5):103-12. PubMed ID: 26717601
[TBL] [Abstract][Full Text] [Related]
15. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
16. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
Chen W; Giger ML; Bick U; Newstead GM
Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
[TBL] [Abstract][Full Text] [Related]
17. Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data.
Makkat S; Luypaert R; Sourbron S; Stadnik T; De Mey J
J Magn Reson Imaging; 2007 Jun; 25(6):1159-67. PubMed ID: 17520720
[TBL] [Abstract][Full Text] [Related]
18. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
Daldrup H; Shames DM; Wendland M; Okuhata Y; Link TM; Rosenau W; Lu Y; Brasch RC
AJR Am J Roentgenol; 1998 Oct; 171(4):941-9. PubMed ID: 9762973
[TBL] [Abstract][Full Text] [Related]
19. A model of the dual effect of gadopentetate dimeglumine on dynamic brain MR images.
Barbier EL; den Boer JA; Peters AR; Rozeboom AR; Sau J; Bonmartin A
J Magn Reson Imaging; 1999 Sep; 10(3):242-53. PubMed ID: 10508283
[TBL] [Abstract][Full Text] [Related]
20. Washout of mass-like benign breast lesions at dynamic magnetic resonance imaging.
Tannaphai P; Trimboli RM; Carbonaro LA; Viganò S; Di Leo G; Sardanelli F
J Comput Assist Tomogr; 2012; 36(3):301-5. PubMed ID: 22592612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
